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At the end of this lecture, you should 
understand:
• The view of DXA BMD as a surrogate for fracture risk in 
terrestrial medicine. Why DXA is not a good research 
technology to understand fracture risk in astronauts.
• Flight data describing the unique effects of spaceflight on 
skeletal sites at risk for age-related osteoporosis on 
Earth.
• Bold research approaches to assessing the 
“biomechanical competence of bone” in the context of 
NASA’s constraints.
BONE BIOLOGY
Getting on the same page.
Cortical Bone/ “Compact Bone”
Sources:  L. Mosekilde; SL Bonnick; P Crompton
PROXIMAL FEMUR
VERTEBRAL BODY – 66% BMD
Cancellous “Spongy” Bone/Trabecular Bone
Trochanter
50% BMD
Femoral Neck
25% BMD
TWO TYPES OF BONE
Entire skeleton turns-over  
10%/year:  3% cortex but 
25% of cancellous bone
Cortical  Bone 80% of 
total skeleton
(long bones)Cancellous Bone 20% of 
total skeleton (vertebrae,
ribs, ends of long bones)
Contains 80% of bone 
surfaces
Distribution of bone types in skeleton 
and turnover rates on earth
Trabecular Surface
Intracortical
Periosteal Surface
BONE SURFACES – Sites of bone formation & 
removal – not random
Endocortical “Endosteal” Surface
Remodeling at the level of a single “Bone 
Remodeling Unit”
HIGHLY-REGULATED ACTIONS OF BONE CELLS on BONE TURNOVER. 
1-2 million BRUs in the adult skeleton
osteoblasts
osteoclasts
osteocytes
TYPES OF BONE CELLS:  mediators of bone resorption, 
bone formation, mechanical sensing
Bone Marrow Area
Mineralized bone
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Characterizing Bone Changes* in Space
SPA=Single Photon Absorptiometry
DXA=Dual-energy X-ray Absorptiometry
QCT=Quantitative Computed Tomography
pQCT = peripheral QCT 
BTO=biochemical markers of bone turnover *Two functions of skeleton
Skylab-Bone Mineral Density of Calcaneus 
(vs. wrist)
Rambaut P, Johnston R. Acta Astronaut. 1979;6:1113-22.
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Functions of the Skeleton*
• Internal support for the body
• Attachment for muscles / tendons for motion
• Protects vital organs
• Encloses blood-forming elements in marrow
• Mobilized store for Calcium (Ca2+) homeostasis
*What potential risks to human health & performance? During and after a mission.
Four identified “Bone” health risks for 
exploration missions.
1. Early Onset Osteoporosis  (fragility fractures)
2. Bone Fracture (trauma fractures)
3. Formation of Renal Stones 
4. Intervertebral Disc Injury (or Damage)
Four Identified “Bone” health risks for 
exploration missions.
1. Early Onset Osteoporosis 
2. Bone Fracture
3. Formation of Renal Stones 
4. Intervertebral Disc Injury (or Damage)
Journal of Bone & Mineral 
June 28(6):1243-1255, 2013
“Bone Summit I – 2010”
1. What additional 
measure(s) do we need 
to monitor?   
2. How frequently? For how 
long?
3. How should Med Ops use 
research data in its 
clinical practice?  
4. Need specific clinical 
practice guidelines.
BONE SUMMIT
2010 and 2013
Flight validation Research
Astronauts Clinical Care
Ground‐Analog Research
Combined Medical and Research Tests:  
Intervention Requirement?, Clinical Triggers?, Surveillance 
Recommendations
Bone Research @ NASA
Take Home Messages from 
Bone Summit (2010)
1. Bone is a complicated tissue.
2. NASA has constraints: low subject #’s; slow data 
acquisition.
3. Astronauts are understudied group.
4. Spaceflight effects on bone are unique.
5. Clinically-accepted tests have limitations.
6. NASA’s medical standards for bone health 
(based upon terrestrial guidelines) are not 
applicable to long-duration astronauts.
7. Recommended exploring the transition of 
research approaches to clinical arena. 
Risk: Different types of fractures
Load > Bone Strength = FRACTURE
(Causality – BIOMECHANICS)
You don’t have to have OSTEOPOROSIS.
“Osteoporotic/Fragility Fractures” –
low to atraumatic Fractures 
due to Osteoporosis
(Causality - SKELETAL CONDITION)
You don’t have to be OLD.
Age (yr)
0
500
1,000
1,500
0 20 40 60 80 100
Age-related Loss
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Peak Bone Mass
Females
Males
Bone mass
(g/calcium)
Riggs BL, Melton LJ:  Adapted from Involutional osteoporosis
Oxford Textbook of Geriatric Medicine
ADAPTED SLIDE COURTESY OF Dr. S. AMIN, Mayo Clinic
Does spaceflight result in irreversible changes to bone 
that combine with age-related losses?
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Increased risk in astronauts? 
Limited time to count incidence of fractures.
Cooper and Melton, 1992SLIDE COURTESY OF Dr. S. AMIN, Mayo Clinic
NASA measures Bone Mineral Density [BMD] 
by DXA as a surrogate for fracture just as clinical 
world.  –T-scores (Not BMD change). circa 2000
Permissible 
Outcome
Limit
Preflight 
Standard
Mitigation
Efficacy
“Osteoporosis is a skeletal disorder characterized by 
compromised bone strength predisposing to an increased 
risk of fracture.  Bone strength reflects the integration of two 
main features:  bone density and bone quality.”  
JAMA.  2001
Disconnects evident
In population studies.
FRACTURE CASES
NON FRACTURES
BONE STRENGTH IS 
INFLUENCED BY ADDITIONAL 
FACTORS THAT ARE NOT 
MEASURED BY DXA AREAL 
BMD.
Widely-applied surrogate for fracture
Diagnostic Guidelines Not Meaningful
for Astronauts
for peri- and postmenopausal women and men > 50 years.
Age is important risk factor for bone loss but
the utility for < 50 years not clearly evident .*
Kanis et al JBMR 9(8):1137, 1994    
* The use of DXA BMD for surveillance of active astronauts is a unique application.
Risk for osteoporotic fractures is lower at younger ages.
Adapted from:
Kanis JA et al. Osteoporosis Int. 2001;12:989-995
Slide Courtesy of S. Petak, MD.
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Probability of first fracture of hip, distal 
forearm, proximal humerus, and 
symptomatic vertebral fracture in 
women of Malmö, Sweden.
Given the probability of fracture drives the requirement for interventions, 
DXA testing for the younger aged is not considered necessary.
WHAT COULD BE MEASURED 
TO DEFINE A RARE RISK IN 
YOUNGER PERSONS?
Uncertainty exists. Are the long-duration astronauts at risk? 
History of Bone Imaging in Space
ApolloMercury
Gemini
Skylab
Space Shuttle
ISS
1961-63 1965-66 1968-72
• X-ray 
densitometry
• SPA  heel 
and wrist
• SPA  heel 
and wrist
1973-74 2000-present
Soyuz/Salyut
1974-85
• SPA  
• DPA
Mir
• DXA whole body
• CT of  lumbar spine 
BMD
1974-85
• DXA
• QCT
• HR3DpQCT
(ESA)
Slide courtesy of S. Amin, adapted from Dr. Jean Sibonga, NASA JSC
Measurement of bone mineral in 2-d projection of bone [BMDa] 
g/cm2
•Improved precision;  Low radiation;  Shorter scan times; BMD measures 
over multiple skeletal sites
• Validated in numerous population studies for fracture prediction
• Long established, widely-applied surrogate for fracture outcome – become 
NASA standards, but T-scores give only Relative Risks
Dual-energy X-ray Absorptiometry-DXA 
Areal BMD 
g/cm2
%/Month 
Change + SD
Lumbar Spine -1.06+0.63*
Femoral Neck -1.15+0.84*
Trochanter -1.56+0.99*
Total Body -0.35+0.25*
Pelvis -1.35+0.54*
Arm -0.04+0.88
Leg -0.34+0.33*
*p<0.01, n=16-18
DXA:  BMD losses are site-specific and 
rapid
Hip
1.5% / month
Whole Body
0.3% / month
Lumbar Spine
1% / month
LeBlanc et al, J Musculoskeletal 2000
vs. 0.5 – 1.0 % BMD loss/year in the aged
* Updated data since 2010 Bone Summit
Note: No population data % BMD loss = Fracture Outcome
Effects of exercise regimens described using DXA BMD
Mary Bouxsein, Ph.D. Bone Geometry and Skeletal Fragility, May 2005
A Limitation: DXA Cannot distinguish changes in 
bone geometry– a contributor to bone strength.
Areal (g/cm2)
Exercise changes geometry of whole bone 
(adult skeleton)- not detected by DXA.
1. Haapasalo H, Sievanan H, Kannus P, Heinonen A, Oja P, Vuori I.  1996  
Dimensions and estimated mechanical characteristics of the humerus after 
long-term tennis loading.  J Bone Miner Res.  11:864-872.
2. Adami S, Gatto D, Braga V, Bianchini D, Rossini M.  1999  Site-specific effects of 
strength training on bone structure and geometry of ultradistal radius in 
postmenopausal women.  J Bone Miner Res.  14(1):120-124.
3. Haapasalo H, Kontulainen S, Sievanen H, Kannus P, Jarvinen M, Vuori I.  2000  
Exercise-induced bone gain is due to enlargement in bone size without a 
change in volumetric bone density: a peripheral quantitative computed 
tomography study of the upper arms of male tennis players.  Bone  17(3):351-
357.
4. Vainionpaa A, Korpelainan R, Sievanen H, Vihriaia E, Leppaluoto J, Jamasa T.  2007  
Effect of impact exercise and its intensity on bone geometry at weight-bearing 
tibia and femur.  Bone  40(3):604-611.  
5. Hind K, Gannon L, Whatley, Cooke C, Truscott J.  2011  Bone cross-sectional 
geometry in male runners, gymnasts, swimmers and non-athletic controls: a 
hip-structural analysis study.  Eur J Appl Physiol .  e pub May 24
33
The location of formed bone makes a 
difference.
Slide courtesy of  M. Bouxsein, PhD
QCT quantifies volumetric BMD
DXA reports areal BMD (aBMD)
Densitometry & Reported Measurement 
g/cm2  averaged for cortical + trabecular bone
g/cm3 for separate  cortical & trabecular bone
Research:  QCT detects different rate of vBMD loss in 
separate bone compartments of hip. (n=16 ISS 
volunteers)
Index 
DXA 
 
%/Month 
Change + SD 
Index 
QCT 
%/Month 
Change + SD 
aBMD Lumbar 
Spine 
1.06+0.63* Integral vBMD 
Lumbar Spine 
 
0.9+0.5 
 
 
 
  Trabecular 
vBMD Lumbar 
Spine 
 
0.7+0.6 
aBMD Femoral 
Neck 
1.15+0.84* Integral vBMD 
Femoral Neck 
 
1.2+0.7 
  Trabecular 
vBMD 
Femoral 
 Neck 
 
2.7+1.9 
aBMD 
Trochanter 
1.56+0.99* Integral vBMD 
Trochanter 
 
1.5+0.9 
*p<0.01,  
n=16-18 
 Trabecular 
vBMD 
Trochanter 
2.2+0.9 
 
LeBlanc, J Musculoskelet Neuronal Interact. 2000 ; 
Lang , J Bone Miner Res, 2004; 
Slide adapted from T. Lang., JBMR 2006.
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QCT Postflight – Changes in Femoral Neck structure 
detected  12 months after return
Structural 
Framework
Mineral
Reservoir
Formation Biochemical Markers
Resorption Biochemical Markers
Osteoblasts
Osteoclasts
Bone 
Resorption
Bone 
Formation
Two Functions of the Skeleton- increasing 
understanding by biochemistry
Serum and urinary biomarkers are by-products of 
bone turnover and bone cell activity.
Serum:
Total and bone-specific alkaline phosphatase (formation)
Osteocalcin (formation)
Total serum Calcium (40% protein bound;  calcium complexes)
Ionized serum Calcium (physiologically active)
Urine:
Pyridinium cross-links (resorption)
Deoxypyridinoline cross-links (resorption)
n-telopeptide (resorption)
Hormones:  (regulation of calcium homeostasis)
Parathyroid hormone – glands - main calcium sensing organ
1,25 Dihydroxyvitamin D -- stimulates Ca conservation
25 Hydroxyvitamin D – assayed vitamin D metabolite (substrate)
Bone breakdown is increased, formation is uncoupled
from resorption, and bone gain and loss are unbalanced*
(Smith et al, JBMR 2005); adapted by Sibonga
Reflects changes in bone cells but not where bone 
mass is lost.  
* Could lead to net bone loss in skeleton.
Remodeling of bone at the level of a single “BRU”
HIGHLY-REGULATED ACTIONS OF BONE CELLS on BONE TURNOVER. 
Under-filling, over-filling, balanced filling of the bone remodeling unit [BRU]
Can impact overall structural strength of whole bone (skeletal region).
1-2 million BRUs in the adult skeleton
Some insight gained by comparison to 
Earth-based disorders of increased bone resorption.
.
(Mosekilde, 2000; Seeman, 2002; Silva, 1997; Kleerekoper, 1985)
Representative manifestation on bone microarchitecture.
Clinical test not currently available for hip/spine.
HOW CAN RESEARCH DATA 
BE USED FOR CLINICAL CARE 
IN THE ABSENCE OF 
FRACTURE EVIDENCE?
Path to Risk Reduction
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DXA BMD increases in Postflight – but not sufficient
to assess recovery of bone strength.
Sibonga et al. BONE 41:973-978, 2007
DXA & QCT Spine in 8 ISS astronauts : 
Expanding our Understanding of Recovery After Spaceflight
QCT Extension Study (n=8) Postflight Trabecular BMD in hip.  Carpenter, D et al. Acta Astronautica, 2010.
L1-L4 L1, L2
DXA & QCT Femoral Neck
QCT Extension Study (n=8) Postflight Trabecular BMD in hip.  Carpenter, D et al. Acta Astronautica, 2010.
Clinical Evidence: QCT measures are independent 
predictors of hip fracture to supplement aBMD.
• Different patterns of bone “loss” (cortical vs. trabecular) with different 
metabolic disorders …analogous to spaceflight effects
Seeman, JCI 1992
Slide courtesy of
Dr. Amin, MD
Dual Photon 
Absorptiometry (DPA)
DXA BMD not as good of predictor of hip fractures for the
“complicated patient” i.e., non-age-related bone loss.
Describing changes in hip bone strength with Finite 
Element Modeling/Analysis: 
Emerging data from population studies. 
• Male-female differences in prediction of hip fracture during finite 
element analysis. Keyak JH, Sigurdsson S, Karlsdottir G, Oskarsdottir D, 
Sigmarsdottir A, Zhao S, Kornak J, Harris TB, Sigurdsson G, Jonsson BY, 
Siggeirsdottir K, Eiriksdottir G, Gudnason V, Lang TR. Bone. 
2011;48(6):1239-1245.
• Association of hip strength estimates by finite –element analysis with 
fractures in women and men. Amin S,, Kopperdahl DL, Melton LJ 3rd, 
Achenbach SJ, Therneau TM, Riggs BL, Keaveny TM, Khosla S. J Bone 
Miner Res. 2011;26(7):1593-1600.
• Age-dependence of femoral strength in white women and men. 
Keaveny TM, Kopperdahl DL, Melton III LJ, Hoffmann PF, Amin S, Riggs 
BL, Khosla S. J Bone Miner Res. 2010;25(5):994-1001.
• Osteoporotic Fractures in Med Study Group. Finite element analysis of 
the proximal femur and hip fracture risk in older men. Orwoll ES, 
Marshall LM, Nielson CM, Cummings SR, Lapidus J, Cauley JA, Ensrud K, 
Lane N, Hoffmann PR, Kopperdahl DL, Keaveny TM J Bone Miner Res. 
2009;24(3):475–483.
Images courtesy of Dr. J Keyak
Finite Element Models of QCT data – “FE modeling” is 
a computational tool to estimate failure loads 
(“strength”) of complex structures.
J. Keyak et al, 1998, 2001, 2005
Individual Results
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QCT estimates fracture loads
better than DXA 
QCT + FEM has superior 
capabilities for estimating fracture 
loads
R2=.66
QCT
R2 =.57
DXA
R2 =.84
FEMDD Cody:  Femoral strength is better predicted  by finite 
element models than QCT and DXA.  J Biomechanics  
32:1013 1999.
QCT + FEM has superior capabilities for 
estimating mechanical strength of ex-vivo 
specimens.
Finite 
Element 
Strength
BMD
Geometry
& Size
Material 
Properties
Loading
Individualized
Fracture Risk
Assessing Fracture risk following spaceflight 
by 1 measure vs > 1 measure.
Bone 
Strength
50-70%
T-scores
Areal BMD
Relative
Fracture Risk
Additional cut-points for Bone Health: FE Modeling of 
QCT Scans from Population Studies
FE Task Group:
E. Orwoll MD, S Khosla MD, S Amin MD, T Lang PhD, J Keyak PhD, T Keaveny PhD, D Cody PhD, 
JD Sibonga, Ph.D.
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Data slide courtesy of Keyak.  REPRESENTATIVE POPULATION DATA
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Probabilistic Risk Assessments for Bone 
Fracture:  NASA’s Model for Fracture Likelihood
Bone Loss in 
Space
courses.washington
.edu/me598rc 
Biomechanics 
and Mission 
Operations
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Characteristics of 
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Slide courtesy of J Myers; Adapted by Sibonga
Summary
• DXA –widely-applied medical test for terrestrial medicine 
but may be too limiting for operational and clinical 
decision-making for bone health of astronauts.
• If skeletal integrity is assessed solely by a surrogate
measure of bone strength (DXA –BMD) vs. an estimate
of bone strength (e.g., FE modeling), then there may be 
a risk of underestimating fracture probability and poorly 
estimating countermeasure efficacy.
• Bone Research in progress to test QCT as a risk 
surveillance technology and to derive new cut-points to 
supplement bone health standards.
QUESTIONS? COMMENTS?
Thank you.
Backup Slides
Study on Risk Surveillance: Hip QCT
• Test feasibility of QCT protocol for 
surveillance of clinical trigger.
• Accumulate surveillance data for 
development of clinical practice 
guidelines (QCT and FEM)
• Research: Demonstrate how QCT 
can delineate biochemical from 
mechanical countermeasures.  
“Proof of Concept” Pilot Study
Figures courtesy of T. Lang (UCSF) and D. Carter (Stanford U)
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AGE-REGRESSIONS: Trabecular bone 
loss occurs at earlier age than expected.
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Vertebral trabecular vBMD
Riggs et al. JBMR19:1945, 2004.
Slide courtesy S. Khosla, adapted by Sibonga
HRP slide courtesy C. Kundrot
Adapted Sibonga 2012
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Use of Osteoporosis Policy-makers help to translate 
research data to CPGs in absence of fracture data.
Evidence Base –
Flight and Ground
• Science
• Clinical
• Operational 
experience
Exploration 
Missions & 
Architectures
NASA Spaceflight 
Human System 
Standards
Risks
Integrated Research Plan
Results and 
Deliverables Solicitations & Directed 
Research
Gaps
Closure 
Metrics
Clinically-relevant
Research Tasks
Effects on Different Compartments of 
Bone (cortical vs. trabecular BMDs)
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Ann Biomed Eng, 37(11), 2009, pg. 2337 - 2359.
ES Nelson et al. Development and validation of a predictive bone fracture risk model for astronauts NASA Glenn Research Center, Cleveland, OH
Different ways to unbalance remodeling at bone surface.
Different levels of cell number 
and cell activities ending in deficit
of bone at the BRU.
Space?
QCT provides useful information re: causation of 
hip fracture, evaluation of hip fracture risk and 
possible targets for intervention.
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ARED exercise appears to mitigate decline in areal BMD.  
(J Bone Mineral Research. Smith et al 2012) * this is not ref for figure.
FE Standards Combine Aging and Spaceflight 
Changes to Hip Strength and used together with 
DXA BMD Standards.
Minimum FE 
strength for Bone 
Health
“Go”
Minimum 
Permissible
Outcome
“Wait”
“No Go”
Steven Goldstein, Ph.D.
“Bone Quality: A Biomechanical Perspective”
QCT in Population Study: Age-related 
Changes
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Suggests that femoral neck total area increases by outward 
displacement when cortex thins with age 
Postmenopausal women
Premenopausal women
**
Riggs et al. JBMR19:1945, 2004.
The long-duration astronaut – not typical 
subject to evaluate osteoporosis (4/2014).
• Typical space mission duration – 159 ± 32d (range 49-215d)
• Average Age – 47 ± 5 y (range 36 – 56)
• Male to Female Ratio – 4.4 : 1
• Current total # per astronauts in corps – 59 of 365
• # repeat fliers – 6
• BMI – Male BMI 25.7 ± 2.2 (range 21.2 to 30.7); Female BMI 
22.2 ± 2.3 (range 20.1 to 25.9)
• Wt and Ht- Males: Males: 81 ± 9 (64 to 101); 176 ± 6 (163 
to 185)
• Females: 64 ± 7 (54 to 81), 169 ± 4 (163 to 178)
• % Body Fat: Males 20 ± 4 (9 to 27); Females 27 ± 8 (19 to 
41)
• MEDICAL PRIVACY A MAJOR CONSTRAINT
Bone Remodeling Sequence
Slide courtesy of Dr. R. Wermers, Mayo Clinic
